Association of Apelin Levels in Overweight-obese Children with Pubertal Development, but Not with Insulin Sensitivity: 6.5 Years Follow up Evaluation

References

• Ogden CL, Carroll MD, Lawman HG, et al. Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013-2014. JAMA. 2016;7:2292–2299. doi:10.1001/jama.2016.6361.
   Google Scholar
• Hagman E, Besor O, Hershkop K. et al. Relation of the degree of obesity in childhood to adipose tissue insulin resistance. Acta Diabetol. 2019;56:219–226. doi:10.1007/s00592-018-01285-3.
   PubMed Web of Science ®Google Scholar
• Kwiterovich PO Jr. Recognition and management of dyslipidemia in children and adolescents. J Clin Endocrinol Metab. 2008;93:4200–4209. doi:10.1210/jc.2008-1270.
   PubMed Web of Science ®Google Scholar
• Pandita A, Sharma D, Pandita D, Pawar S, Tariq M, Kaul A. Childhood obesity: prevention is better than cure. Diabetes Metab Syndr Obes. 2016;9:83–89. doi:10.2147/DMSO.S90783.
   PubMed Web of Science ®Google Scholar
• Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic risks and severity of obesity in children and young adults. N Engl J Med. 2015;373:1307–1317. doi:10.1056/NEJMoa1502821.
   PubMed Web of Science ®Google Scholar
• Valerio G, Maffeis C, Saggese G, et al. Diagnosis, treatment and prevention of pediatric obesity: consensus position statement of the Italian society for pediatric endocrinology and diabetology and the Italian society of pediatrics. Ital J Pediatr. 2018;31(44):88. doi:10.1186/s13052-018-0525-6.
   Google Scholar
• Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011-2014. NCHS Data Brief. 2015 Nov;(219):1-8. PubMed PMID: 26633046.
   Google Scholar
• Zhang T, Xu J, Li S, et al. Trajectories of childhood BMI and adult diabetes: the Bogalusa heart study. Diabetologia. 2019;62:70–77. doi:10.1007/s00125-018-4753-5.
   PubMed Web of Science ®Google Scholar
• Boucher J, Masri B, Daviaud D, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146:1764–1771. Epub 2005 Jan 27. PubMed PMID:15677759. doi:10.1210/en.2004-1427.
   PubMed Web of Science ®Google Scholar
• Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998;251:471–476. PubMed PMID: 9792798. doi:10.1006/bbrc.1998.9489.
   PubMed Web of Science ®Google Scholar
• Medhurst AD, Jennings CA, Robbins MJ, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem. 2003;84:1162–1172. PubMed PMID:12603839. doi:10.1046/j.1471-4159.2003.01587.x.
   PubMed Web of Science ®Google Scholar
• Castan-Laurell I, Dray C, Knauf C, Kunduzova O, Valet P. Apelin, a promising target for type 2 diabetes treatment? Trends Endocrinol Metab. 2012;23:234–241. doi:10.1016/j.tem.2012.02.005.
   PubMed Web of Science ®Google Scholar
• Taheri S, Murphy K, Cohen M, et al. The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun. 2002;291:1208–1212. PubMed PMID: 11883945. doi:10.1006/bbrc.2002.6575.
   PubMed Web of Science ®Google Scholar
• O’Carroll AM, Don AL, Lolait SJ. APJ receptor mRNA expression in the rat hypothalamic paraventricular nucleus: regulation by stress and glucocorticoids. J Neuroendocrinol. 2003;15:1095–1101. PubMed PMID: 14622440. doi:10.1046/j.1365-2826.2003.01102.x.
   PubMed Web of Science ®Google Scholar
• Bertrand C, Valet P, Castan-Laurell I. Apelin and energy metabolism. Front Physiol. 2015;10(6):115. doi:10.3389/fphys.2015.00115.
   Google Scholar
• Cavallo MG, Sentinelli F, Barchetta I. et al. Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus. PLoS One. 2012;7:e51236. doi:10.1371/journal.pone.0051236.
   PubMed Web of Science ®Google Scholar
• Hosoya M, Kawamata Y, Fukusumi S, et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem. 2000;275:21061–21067. PubMed PMID:10777510. doi:10.1074/jbc.M908417199.
   PubMed Web of Science ®Google Scholar
• Gourdy P, Cazals L, Thalamas C. et al. Apelin administration improves insulin sensitivity in overweight men during hyperinsulinaemic-euglycaemic clamp. Diabetes Obes Metab. 2018;20:157–164. doi:10.1111/dom.13055.
   PubMed Web of Science ®Google Scholar
• Castan-Laurell I, Vítkova M, Daviaud D. et al. Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ. Eur J Endocrinol. 2008;158:905–910. doi:10.1530/EJE-08-0039.
   PubMed Web of Science ®Google Scholar
• Heinonen MV, Purhonen AK, Miettinen P, et al. Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regul Pept. 2005;130:7–13. PubMed PMID: 15970339. doi:10.1016/j.regpep.2005.05.003.
   PubMed Web of Science ®Google Scholar
• Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, et al. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg. 2009;19:1574–1580. doi:10.1007/s11695-009-9955-y.
   PubMed Web of Science ®Google Scholar
• Ba HJ, Chen HS, Su Z, et al. Associations between serum apelin-12 levels and obesity-related markers in Chinese children. PLoS One. 2014;27(9):e86577. doi:10.1371/journal.pone.0086577.
   Google Scholar
• Kotanidou EP, Kalinderi K, Kyrgios I. et al. Apelin and G212A apelin receptor gene polymorphism in obese and diabese youth. Pediatr Obes. 2015;10:213–219. doi:10.1111/ijpo.251.
   PubMed Web of Science ®Google Scholar
• Reinehr T, Woelfle J, Roth CL. Lack of association between apelin, insulin resistance, cardiovascular risk factors, and obesity in children: a longitudinal analysis. Metabolism. 2011;60:1349–1354. doi:10.1016/j.metabol.2011.02.005.
   PubMed Web of Science ®Google Scholar
• Cacciari E, Milani S, Balsamo A, et al. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest. 2006;29(7):581–593. PubMed PMID: 16957405. doi:10.1007/BF03344156.
   PubMed Web of Science ®Google Scholar
• Tanner JM. Normal growth and techniques of growth assessment. Clin Endocrinol Metab. 1986;15:411–451. PubMed PMID: 3533329. doi: 10.1016/S0300-595X(86)80005-6.
   PubMedGoogle Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. PubMed PMID: 3899825. doi:10.1007/BF00280883.
   PubMed Web of Science ®Google Scholar
• Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462–1470. PubMed PMID: 10480510. doi:10.2337/diacare.22.9.1462.
   PubMed Web of Science ®Google Scholar
• Cambuli VM, Incani M, Cossu E. et al. Prevalence of type 1 diabetes autoantibodies (GADA, IA2, and IAA) in overweight and obese children. Diabetes Care. 2010;33:820–822. doi:10.2337/dc09-1573.
   PubMed Web of Science ®Google Scholar
• Kelsey MM, Zeitler PS. Insulin resistance of puberty. Curr Diab Rep. 2016;16(7):64. doi:10.1007/s11892-016-0751-5.
   PubMed Web of Science ®Google Scholar
• Hannon TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res. 2006;60:759–763. PubMed PMID: 17065576. doi:10.1203/01.pdr.0000246097.73031.27.
   PubMed Web of Science ®Google Scholar
• Moran A, Jacobs DR Jr, Steinberger J, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999;48:2039–2044. PubMed PMID: 10512371. doi:10.2337/diabetes.48.10.2039.
   PubMed Web of Science ®Google Scholar
• Ball GD, Huang TT, Gower BA, et al. Longitudinal changes in insulin sensitivity, insulin secretion, and beta-cell function during puberty. J Pediatr. 2006;148:16–22. PubMed PMID: 16423592. doi:10.1016/j.jpeds.2005.08.059.
   PubMed Web of Science ®Google Scholar
• Saenger P. Metabolic consequences of growth hormone treatment in paediatric practice. Horm Res. 2000;53 Suppl 1:60–69. PubMed PMID: 10895045. doi:10.1159/000053207.
   PubMedGoogle Scholar
• Caprio S. Insulin resistance in childhood obesity. J Pediatr Endocrinol Metab. 2002;15(Suppl 1):487–492. PubMed PMID: 12017221.
   PubMed Web of Science ®Google Scholar
• Moran A, Jacobs DR Jr, Steinberger J, et al. Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females. Circulation. 2008;117:2361–2368. doi:10.1161/CIRCULATIONAHA.107.704569.
   PubMed Web of Science ®Google Scholar
• Boshuizen HC, Viet AL, Picavet HS, Botterweck A, van Loon AJ. Non-response in a survey of cardiovascular risk factors in the Dutch population: determinants and resulting biases. Public Health. 2006;120:297–308. PubMed PMID: 16364384. doi:10.1016/j.puhe.2005.09.008.
   PubMed Web of Science ®Google Scholar
• Toledano MB, Smith RB, Brook JP, Douglass M, Elliott P. How to establish and follow up a large prospective cohort study in the 21st century–lessons from UK COSMOS. PLoS One. 2015;10:e0131521. doi:10.1371/journal.pone.0131521.
   PubMed Web of Science ®Google Scholar